Virginia Kan, MD, a graduate of Cornell University Medical College, completed her Internal Medicine residency at Boston City Hospital, her Infectious Diseases fellowship at the National Institute of Allergy and Infectious Diseases, and her Dalldorf Medical Mycology fellowship in the laboratory of Dr. John E. Bennett. Dr. Kan joined the Infectious Diseases Section of the Washington DC VA Medical Center in 1991, where she is also the Director of the Infectious Diseases Laboratory serving as a regional reference laboratory for HIV, HCV, chlamydia, gonorrhea and SAR-CoV-2 molecular testing. She is currently Chief of the Infectious Diseases Section at the Washington DC VA Medical Center and Professor of Medicine at George Washington University. Her research interests have included host defense mechanisms and animal models of medical mycoses and expansion of HIV testing and HCV treatment in the VA setting. She has worked with ID fellows in on their research projects using the VA databases as well as HIV and Hepatitis Case Registries.
Dr. Kan is the Principal Investigator of the Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit with AIDS Clinical Trials Group (ACTG) Clinical Research Sites in Houston and Lima, Peru and HIV Prevention Trials Network (HPTN) Clinical Research Sites in Houston and Washington, DC. She is the leader of the Washington International Coordinating Center for the INSIGHT network with current clinical trials in HIV and influenza with sites in the United States, South America and Africa. The INSIGHT network has active global studies on COVID-19: an observational study, a master protocol evaluating SARS-CoV-2 monoclonal antibodies [ACTIV 3] and a SARS-CoV-2 hyperimmune immunoglobulin trial.
Dr. Kan’s teaching awards include the Veterans Affairs Medical Center Attending of the Year 2001-2002 and the Sol Katz Teaching Award from the DC Chapter of the American College of Physicians in 2007.